Gender Disparity

A registry of drug-eluting devices for the treatment of patients with peripheral arterial disease is meeting its enrollment goals for women and patients from historically underrepresented backgrounds, researchers reported at VIVA 22.

CHARLOTTE, N.C. — As his presidency comes to a close, Samir A. Shah, MD, FACG, reflected on the progress made during his tenure, with significant strides in expanding representation and diversity within ACG.

In middle-aged women, kidney function declined slower than it did in men the same age or older during aging, according to a study in the Journal of the American Society of Nephrology.

Among patients who had catheter ablation for atrial fibrillation, women were more likely than men to require hospitalization for more than 1 day, to have major adverse events and to have poor quality of life outcomes, researchers reported.

In this video, Erminia Massarelli, MD, PhD, MS, co-director of the lung cancer and thoracic oncology program, and associate professor in the department of medical oncology and therapeutics research at City of Hope Cancer Center in Duarte, California, highlights disparities that exist in the treatment.